These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Study of the immunosuppressive effect of some anticonvulsants in children]. Massimo L; Pasino M; Rosanda Vadalá C; Tonini GP; Perutelli P; Saccomani L Minerva Pediatr; 1977 Apr; 29(12):837-41. PubMed ID: 327255 [No Abstract] [Full Text] [Related]
23. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment. Ertam I; Sezgin AO; Unal I Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064 [No Abstract] [Full Text] [Related]
24. Neuroblastoma, maternal valproic acid use, in-vitro fertilization and family history of mosaic chromosome 22: coincidence or causal relationship? Merks JH; Ceelie N; Caron HN; Hennekam RC Clin Dysmorphol; 2004 Jul; 13(3):197-198. PubMed ID: 15194961 [TBL] [Abstract][Full Text] [Related]
26. Valproate-associated stomatitis. Ryan M; Baumann RJ; Miller CS; Baker C J Child Neurol; 2002 Mar; 17(3):225-7. PubMed ID: 12026241 [TBL] [Abstract][Full Text] [Related]
27. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid]. Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420 [TBL] [Abstract][Full Text] [Related]
28. [Fatal hepatic necrosis during treatment with sodium valproate]. Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902 [TBL] [Abstract][Full Text] [Related]
29. Possible carbamazepine-induced reversible onychomadesis. Mishra D; Singh G; Pandey SS Int J Dermatol; 1989 Sep; 28(7):460-1. PubMed ID: 2777446 [No Abstract] [Full Text] [Related]
31. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period]. Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163 [No Abstract] [Full Text] [Related]
32. Valproic acid therapy inducing absence status evolving into generalized seizures. Shahar E; Andraus J; Sagie-Lerman T; Savitzki D Pediatr Neurol; 2002 May; 26(5):402-4. PubMed ID: 12057805 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of epileptic seizures resistant to phenobarbital in children during the first year of life]. Rudenko AIu; Konoplianko TV; Stetsiuk RA Lik Sprava; 2002; (1):52-6. PubMed ID: 11944381 [TBL] [Abstract][Full Text] [Related]
34. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke. Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540 [TBL] [Abstract][Full Text] [Related]
35. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy]. Ono H No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458 [No Abstract] [Full Text] [Related]